Algo version: 0.98b
Kangmei Pharmaceutical is listed at the SHH Exchange
Kangmei Pharmaceutical [600518.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Kangmei Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Kangmei Pharmaceutical pays dividends. Last time was Wednesday 28th of August 2019 where the investors holding the stock on Wednesday 28th of August 2019 were paid CNY0.024 per share. Over the last 19 times between 2001 and 2019, Kangmei Pharmaceutical has paid CNY2.8042 with an average of CNY0.15 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Kangmei Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY3.51, you would have made a loss of CNY-1.750 per share or -49.86%

Yes, the average daily trading liquidity for Kangmei Pharmaceutical is CNY104.62 million. You should therefore be able to get in and out of your positions relatively fast.

Kangmei Pharmaceutical has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 3.25%, which is challenging.

We have calculated the inflation risk for Kangmei Pharmaceutical to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.